发明名称 |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF MEMBRANE PROTEINS |
摘要 |
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules. |
申请公布号 |
US2016289674(A1) |
申请公布日期 |
2016.10.06 |
申请号 |
US201615174219 |
申请日期 |
2016.06.06 |
申请人 |
Moderna Therapeutics, Inc. |
发明人 |
Bancel Stephane;Chakraborty Tirtha;de Fougerolles Antonin;Elbashir Sayda M.;John Matthias;Roy Atanu;Whoriskey Susan;Wood Kristy M.;Hatala Paul;Schrum Jason P.;Ejebe Kenechi;Ellsworth Jeff Lynn;Guild Justin |
分类号 |
C12N15/11;A61K9/00 |
主分类号 |
C12N15/11 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated polynucleotide comprising;
(a) a first region of linked nucleosides, said first region encoding a polypeptide of interest, said polypeptide of interest selected from the group consisting of SEQ ID NOs 8144-16131; (b) a first flanking region located at the 5′ terminus of said first region comprising;
(i) a sequence of linked nucleosides selected from the group consisting of the native 5′ UTR of any of the nucleic acids that encode any of SEQ ID NOs 8144-16131, SEQ ID NOs: 1-4 and functional variants thereof; and(ii) at least one 5′ terminal cap; (c) a second flanking region located at the 3′ terminus of said first region comprising;
(i′) a sequence of linked nucleosides selected from the group consisting of the native 3′ UTR of any of the nucleic acids that encode any of SEQ ID NOs 8144-16131, SEQ ID NOs 5-21 and functional variants thereof; and(ii′) a 3′ tailing sequence of linked nucleosides. |
地址 |
Cambridge MA US |